Another study shows good results with neoadjuvant immunotherapy in patients with locally advanced dMMR/MSI-H colorectal cancer, leading the authors to suggest it as a new standard of care.
Medscape Medical News
New Standard of Care for Early dMMR/MSI-H Colorectal Cancer?
